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Abstract
Background
To present the rationale for the new Obsessive–Compulsive and Related Disorders (OCRD) grouping in
the Mental and Behavioural Disorders chapter of the Eleventh Revision of the World Health
Organization’s International Classification of Diseases and Related Health Problems (ICD-11), including
the conceptualization and essential features of disorders in this grouping.

Methods
Review of the recommendations of the ICD-11 Working Group on the Classification for OCRD. These
sought to maximize clinical utility, global applicability, and scientific validity.

Results
The rationale for the grouping is based on common clinical features of included disorders including
repetitive unwanted thoughts and associated behaviours, and is supported by emerging evidence from
imaging, neurochemical, and genetic studies. The proposed grouping includes obsessive–compulsive
disorder, body dysmorphic disorder, hypochondriasis, olfactory reference disorder, and hoarding
disorder. Body-focused repetitive behaviour disorders, including trichotillomania and excoriation
disorder are also included. Tourette disorder, a neurological disorder in ICD-11, and personality
disorder with anankastic features, a personality disorder in ICD-11, are recommended for crossreferencing.

Limitations
Alternative nosological conceptualizations have been described in the literature and have some merit
and empirical basis. Further work is needed to determine whether the proposed ICD-11 OCRD grouping
and diagnostic guidelines are mostly likely to achieve the goals of maximizing clinical utility and global
applicability.

Conclusion
It is anticipated that creation of an OCRD grouping will contribute to accurate identification and
appropriate treatment of affected patients as well as research efforts aimed at improving our
understanding of the prevalence, assessment, and management of its constituent disorders.

Keywords
ICD-10, ICD-11, Obsessive–Compulsive Disorder, Classification, Global public health

1. Introduction
The constitution of the World Health Organization (WHO) assigns to WHO responsibility for
establishing and revising “international nomenclatures of diseases” and for standardizing “diagnostic
procedures” (WHO, 2014). One of the ways this mandate is achieved is through the publication of the
International Classification of Diseases and Related Health Problems (WHO, 1992). The eleventh
revision (ICD-11) is being prepared for presentation to the World Health Assembly in 2018. The WHO
Department of Mental Health and Substance Abuse, which is responsible for coordinating the Chapter
on Mental and Behavioural Disorders in ICD-11, appointed Working Groups to develop
recommendations and draft diagnostic guidelines. These proposals will be used as a basis for field
testing (Evans et al., 2015, Keeley et al., in press), results of which will inform the finalization of the
ICD-11.
This article provides an overview of the proposals of the ICD-11 Working Group on Obsessive–
Compulsive and Related Disorders. Proposals were guided by WHO’s mandate that ICD-11 must reflect
current scientific evidence and seek to maximize clinical utility and global applicability. A more clinically
useful ICD-11 would provide a more effective tool to clinicians in varied settings with different levels of
resources for identifying individuals in need of mental health services, diagnosing their conditions, and
selecting treatment strategies (International Advisory Group for the Revision of ICD-10 Mental and
Behavioural Disorders, 2011; Reed et al., 2013). This would most effectively support WHO’s goal of
reducing the global disease burden of mental disorders (WHO, 2013). The Clinical Descriptions and
Diagnostic Guidelines for ICD-11 Mental and Behavioural Disorders are being developed in line with
these priorities (First et al., 2015) and these considerations guided the Working Group in developing its
recommendations.
The Working Group proposed the introduction of a new grouping of Obsessive–Compulsive and
Related Disorders (OCRD), including the existing categories of obsessive–compulsive disorder (OCD)
and hypochondriasis. Body dysmorphic disorder is proposed for inclusion as a separate diagnostic
entity, as well as a new, related category of olfactory reference disorder. The new category of hoarding
disorder is also proposed for inclusion. In addition, a subgrouping of Body-Focused Repetitive
Behaviour Disorders is proposed, including the existing category of trichotillomania (hair-pulling

disorder) and the new category of excoriation (skin-picking) disorder. Tourette disorder will be
included with other Primary Tic Disorders in the ICD-11 chapter on Diseases of the Nervous System, but
will be cross-referenced to the OCRD grouping.
This is a clear change from the ICD-10, which does not include a separate OCRD grouping. In the ICD10, OCD is classified under the broad grouping of Neurotic, Stress-related, and Somatoform disorders,
which also includes hypochondriacal disorder as part of a sub-grouping of Somatoform Disorders. The
ICD-10 does not include a separate category for body dysmorphic disorder, but rather includes it under
hypochondriacal disorder. Trichotillomania appears in the ICD-10 in a different broad grouping of
Disorders of Adult Personality and Behaviour, as a part of subgrouping of Habit and Impulse Disorders.
Tourette syndrome appears in the ICD-10 as a part of the grouping of Behavioural and Emotional
Disorders with Onset Usually Occurring in Childhood and Adolescence, as part of a subgrouping of Tic
Disorders.
The rationale for bringing these disparate entities in ICD-10 together in an OCRD grouping is based on
evidence that existing as well as newly described disorders share core features of unwanted thoughts
and related repetitive behaviours (Phillips et al., 2010, Stein, 2000). In addition, the proposal reflects
evidence that OCD and related disorders share higher than expected familiality (Bienvenu et al., 2012),
genetic risk factors (Monzani et al., 2014), underlying neurocircuitry anomalies (Milad and Rauch,
2012), and neurochemical (Nikolaus et al., 2010) abnormalities. In addition, they frequently co-occur
(Lochner et al., 2005) and some share similar responses to specific psychopharmacological and
psychological treatments (Fineberg et al., 2014).
The Working Group made recommendations with awareness of a range of perspectives on
classification of OCRD. For example, some researchers have argued that because anxiety is observed in
OCD and hypochondriasis, an OCRD grouping should not be separate from a grouping of Anxiety and
Fear-Related Disorders (Storch et al., 2008). Others have argued for a broader construct of the OCRD
category, with the most inclusive proposals suggesting an impulsive–compulsive continuum that would
encompass OCRD as well as obsessive–compulsive personality disorder (Fineberg et al., 2007),
impulsive control disorders, attention deficit hyperactivity disorder (Abramovitch et al., 2012,
Hollander and Wong, 1995), and even substance abuse disorders and feeding and eating disorders
(Robbins et al., 2012). The Working Group determined that an OCRD grouping with the diagnostic
entities in Table 1 optimally balances clinical utility with current evidence. The proposed OCRD
grouping will be located in the ICD-11 immediately following the grouping of Anxiety and Fear-Related
Disorders given their phenomenological and psychobiological similarities. It is hoped that an OCRD
grouping will prompt clinicians to better recognize, assess, and treat these conditions and will
stimulate research based on a more accurate conceptualization of these serious disorders, ultimately
supporting WHO’s objective of improving global mental health and reducing the associated disease
burden.

Table 1. Proposed ICD-11 categories of Obsessive–Compulsive and Related Disorders.
Proposed ICD-11
Essential (required) features
categories
Obsessive–compulsive ● Presence of obsessions and/or compulsions.
disorder
○ Obsessions are repetitive and persistent thoughts (e.g., of
contamination), images (e.g., of violent scenes), or impulses/urges
(e.g., to stab someone) that are experienced as intrusive, unwanted,
and are commonly associated with anxiety. The individual attempts
to ignore or suppress obsessions or to neutralize them by
performing compulsions.

Previous ICD-10 code,
F42

○ Compulsions (or rituals) are repetitive behaviours (e.g., washing,
checking) or mental acts (e.g., repeating words silently) that the
individual feels driven to perform in response to an obsession,
according to rigid rules, or to achieve a sense of “completeness”
• Obsessions and compulsions must be time-consuming (e.g., take more
than 1 h per day) to warrant the diagnosis.
• The symptoms result in significant distress or significant impairment in
personal, family, social, educational, occupational, or other important areas
of functioning.

Body dysmorphic
disorder

• Persistent preoccupation (e.g., at least one hour a day) with one or more
perceived defects or flaws in appearance, or ugliness in general, that is
either unnoticeable or only slightly noticeable to others.
• Excessive self-consciousness about the perceived defect(s) or flaw(s),
often including ideas of self-reference [i.e., the conviction that people are
taking notice, judging, or talking about the perceived defect(s) or flaw(s)].

•The preoccupation is manifest by any of the following:
○ repetitive and excessive behaviours, such as repeatedly examining
of appearance or the severity of the perceived defect(s) or flaw(s)
Previous ICD-10 code,
(e.g., by checking in reflective surfaces or by comparing the relevant
F45.22
feature with that of others);
○ attempts to camouflage or alter the defect (e.g., by undergoing
unnecessary cosmetic surgical procedures);
○ attempts to avoid social situations or triggers that increase distress
about the perceived defect(s) or flaw(s).

Proposed ICD-11
categories

Essential (required) features
• The symptoms result in significant distress or significant impairment in
personal, family, social, educational, occupational, or other important areas
of functioning.

Olfactory reference
disorder

• Persistent preoccupation (e.g., at least one hour a day) with a perceived
foul or offensive body odour or breath (i.e., halitosis) that is either
unnoticeable or slightly noticeable to others such that the individual’s
concerns are markedly disproportionate to the smell, if any.
• Excessive self-consciousness about the perceived odour, often including
ideas of self-reference (i.e., the conviction that people are taking notice,
judging, or talking about the odour).
• The preoccupation is manifest by any of the following:
○ repetitive and excessive behaviours, such as repeatedly checking
for body odour by checking the perceived source of the smell, their
clothing, or repeatedly seeking reassurance;

New category

○ attempts to camouflage the perceived odour by using perfume or
deodorant;
○ attempts to prevent the odour by bathing or brushing teeth, or by
changing clothing, or by avoiding or ingesting certain foods;
○ attempts to avoid social situations or triggers that increase distress
about the perceived foul or offensive odour.
• The symptoms result in significant distress or significant impairment in
personal, family, social, educational, occupational, or other important areas
of functioning.

Hypochondriasis (health • Persistent preoccupation (e.g., at least one hour a day) or fear about the
anxiety disorder)
possibility of having one or more serious, progressive or life-threatening
illnesses.
• The preoccupation is associated with catastrophic misinterpretations of
Previous ICD-10 code, bodily signs or symptoms, including normal or commonplace sensations
(e.g., worrying that a tension headache is indicative of a brain tumour).
F45.2
• The preoccupation is manifest either in:

Proposed ICD-11
categories

Essential (required) features
○ repetitive and excessive health-related behaviours, such as
repeatedly checking of the body for evidence of illness, spending
inordinate amounts of time searching for information about the
feared illness, repeatedly seeking reassurance (e.g., arranging
multiple medical consultations); or
○ maladaptive avoidance behaviour related to health (e.g., avoids
medical appointments).
• The symptoms result in significant distress or significant impairment in
personal, family, social, educational, occupational or other important areas
of functioning.

Hoarding disorder

• Excessive acquisition of, and failure to discard, possessions, regardless of
their actual value. Items may be hoarded because of their emotional
significance (e.g., association with a significant event, person, place, or
time), instrumental characteristics (e.g., perceived usefulness), or intrinsic
value (e.g., perceived aesthetic qualities).
• Excessive acquisition is characterized by repetitive urges and/or
behaviours related to buying, stealing or amassing items, including those
that are free.

New category

• Difficulty discarding items due to a perceived need to save items and
distress associated with discarding them.
• Items are accumulated to a degree that living spaces become cluttered
and their use or safety is compromised.
• The symptoms result in significant distress or significant impairment in
personal, family, social, educational, occupational or other important areas
of functioning.

Body-Focused Repetitive
Behaviour Disorders,
New subgrouping
Trichotillomania (hair- • Repetitive and persistent pulling of one’s hair.
pulling disorder)
• Attempts to stop or decrease hair-pulling.
Previous ICD-10 code,
• Hair loss results from pulling behaviour.
F63.3

Proposed ICD-11
categories

Essential (required) features
• The symptoms result in significant distress or significant impairment in
personal, family, social, educational, occupational or other important areas
of functioning.

Excoriation (skinpicking) disorder

• Repetitive and persistent picking of one’s skin.
• Attempts to stop or decrease skin-picking.
• Skin lesions resulting from picking behaviour.

New category

• The symptoms result in significant distress or significant impairment in
personal, family, social, educational, occupational or other important areas
of functioning.

The sections that follow describe the diagnostic entities proposed for inclusion in the OCRD grouping,
including the rationale for the delineation of the essential features of each disorder (see Table 1) and
the evidence supporting its inclusion.

2. Obsessive–Compulsive Disorder
The proposed ICD-11 diagnostic guidelines for obsessive-compulsive disorder (OCD) retain the core
features of the disorder as conceptualized in ICD-10: the presence of obsessions and/or compulsions
(Stein et al., 2014). However, subsequent research has provided additional evidence regarding the
clinical heterogeneity of the disorder, its underlying neurobiological mechanisms, and its
differentiation from normality and from other mental health and medical conditions. Such evidence
has been incorporated into the ICD-11 diagnostic guidelines for OCD (see Table 1 for core diagnostic
features).
The Working Group recommended that the definition of obsessions in OCD be broadened to capture
the range of experiences described in the literature. The proposed diagnostic guidelines define
obsessions as including repetitive and persistent thoughts (e.g., of contamination), images (e.g., of
violent scenes), or impulses/urges (e.g., to stab someone) that are experienced as intrusive, unwanted,
and are commonly associated with anxiety. This definition acknowledges that sensory as well as
cognitive phenomena can precede compulsive behaviour (Ferrao et al., 2012, Shavitt et al., 2014).
Although obsessions in ICD-11 are described as commonly associated with anxiety, the proposed
diagnostic guidelines also acknowledge the broad range of affective experiences that may be
associated with obsessions, including strong feelings of disgust (Husted et al., 2006, Olatunji et al.,
2011) or a distressing sense of “incompleteness” or uneasiness until things look, feel, or sound, “just
right” (Ferrao et al., 2012). The heterogeneity of affective experiences related to obsessions is one

factor that distinguishes OCD from Anxiety and Fear-Related Disorders and contributes to the rationale
for a separate OCRD grouping.
Another reason for recommending relatively inclusive terminology is that the ICD-11 will be translated
into many languages in which it may not be possible to distinguish between terms that are related but
distinct in English (e.g., “impulse” as opposed to “urge”). The Working Group considered whether this
definition of obsessions could unintentionally reduce clinicians’ ability to differentiate OCD
symptomatology from “impulses” in Impulse Control Disorders and “urges” in Disorders Due to
Substance Use. This was addressed by specifying that the mental phenomena in OCD are experienced
as intrusive, unwanted, and commonly associated with anxiety or distress, and that behaviours
undertaken in response to obsessions (i.e., compulsions) are not experienced as pleasurable, although
they may result in temporary relief from anxiety or distress. This distinguishes impulses or urges in OCD
from appetitive experiences in Disorders Due to Substance Use and from short-term rewarding
behaviours in Impulse Control Disorders, despite partially overlapping terminology.
The proposed ICD-11 diagnostic guidelines also better represent the phenomenology of compulsions in
OCD and differentiate them from repetitive behaviours in other disorders. Compulsions are defined as
repetitive behaviours (e.g., washing, checking) or mental acts (e.g., repeating words silently) that the
individual feels driven to perform in response to an obsession, according to rigid rules, or to achieve a
sense of “completeness.” In ICD-10, compulsions are described as repetitive stereotyped behaviours,
but this confuses compulsions in OCD with stereotypies in other disorders such as autism spectrum
disorder and stereotyped movement disorder. Consistent with the literature, the proposed ICD-11
definition of compulsions also includes covert repetitive behaviours (i.e., mental rituals) rather than
being restricted to repetitive behavioural acts (Foa et al., 1995).
The ICD-11 proposal does not specify a duration requirement for a positive diagnosis of OCD because
there is no empirical support for a particular threshold. Rather, clinicians are prompted to exercise
caution in assigning a diagnosis of OCD to patients who present with a very short duration of illness
(e.g., less than 1 month) and in excluding other etiologies in cases of acute or fulminant onset of OCD
symptoms, particularly in children (Singer, 2011, Swedo et al., 1998).
The proposed ICD-11 diagnostic guidelines describe a functional relationship between obsessions and
compulsions (Foa et al., 1995), specifying that individuals with OCD typically feel driven to perform
compulsions in response to obsessions, often to reduce affective reactions. This is based on
contemporary cognitive-behavioural models of OCD (McKay et al., 2015) and is intended to improve
clinical utility by assisting assessment of OCD and planning treatments such as exposure and response
prevention. Furthermore, specifying this functional relationship differentiates OCD from disorders that
may involve repetitive, intrusive thoughts without concomitant compulsions (e.g., rumination in
depressive disorders, re-experiencing of traumatic events in PTSD, worries in generalized anxiety
disorder) as well as from disorders involving repetitive behaviours that are not performed in response
to obsessions (e.g., trichotillomania, stereotyped movement disorder, autism spectrum disorder).

Inclusion of this functional linkage between obsessions and compulsions is intended to enhance clinical
utility but it does not imply that a causal relationship has been conclusively demonstrated. In fact,
recent functional imaging studies suggest that obsessions may be a consequence rather than a cause of
excessive habit formation (i.e., compulsive behaviours) (Gillan and Robbins, 2014).
Several elements of the ICD-10 classification of OCD are recommended for elimination either because
they do not reflect current research or are not clinically useful for treatment recommendations or
outcomes. Thus, the OCD subtypes in ICD-10—predominantly obsessional thoughts or ruminations,
predominantly compulsive acts [obsessional rituals], mixed obsessional thoughts and acts—are
recommended for deletion in ICD-11 because they have no predictive validity with respect to response
to treatment (Foa et al., 1995) and the majority of patients have both obsessions and compulsions
(Shavitt et al., 2014). The ICD-10 diagnostic guidelines for OCD also contain somewhat confusing
instructions that a depressive disorder diagnosis should be given primacy over OCD; diagnostic cooccurrence of OCD and depressive disorder is permitted under the proposed ICD-11 diagnostic
guidelines. This change is based on evidence that OCD often precedes depressive disorders (Ruscio et
al., 2010), outlasts typical depressive episodes and is more likely to be chronic rather than episodic
(Ravizza et al., 1997, Skoog and Skoog, 1999), and can be distinguished from depressive disorders in
community samples (Weissman et al., 1994). Giving primacy to depressive disorders may have led to
underreporting of OCD when using ICD-10. Finally, in recognition of the high degree of co-occurrence
of OCD and Tic Disorders (Cohen et al., 2013) as well as a putative genetic association (Mathews and
Grados, 2011), the ICD-11 proposal specifies that assigning both OCD and a Tic Disorder is permitted.

3. Body dysmorphic disorder
In ICD-10, body dysmorphic disorder is not a separate category, but appears as an inclusion term under
hypochondriacal disorder. This suggests that body dysmorphic disorder should be diagnosed in ICD-10
as hypochondriacal disorder, although the ICD-10 provides at least three additional possible diagnostic
options for this phenomenon, depending largely on the extent to which beliefs associated with body
dysmorphic disorder are interpreted as delusional (Veale and Matsunaga, 2014). In recognition of its
distinct symptomatology (Phillips, 1991, Phillips et al., 2005, Veale, 2004, Veale et al., 1996) and
prevalence in the general population (Koran et al., 2008, Rief et al., 2006), the Working Group has
recommended that body dysmorphic disorder be included as a separate disorder category.
Individuals with body dysmorphic disorder are persistently preoccupied with one or more defects or
flaws in their bodily appearance (Veale, 2004) that are either unnoticeable or only slightly noticeable to
others. Any part of the body may be the focus of the perceived defects but most commonly these
involve the face, especially the facial skin, nose, hair, eyes, teeth, lips, chin or face in general.
Frequently, there are multiple perceived defects (Phillips and Diaz, 1997, Veale et al., 1996). Individuals
with body dysmorphic disorder are excessively self-conscious about the perceived defects or flaws,
often to the point of manifesting ideas of self-reference (see Table 1). They may fear rejection,
humiliation or, in some cultures, causing offence to others.

The ICD-11 proposal also emphasizes that the persistent preoccupation must be accompanied by
repetitive behaviours (e.g., mirror checking), camouflaging or altering (surgically or otherwise), or
avoidance of anxiety-provoking situations (Phillips, 1991, Phillips et al., 2005, Veale, 2004, Veale et al.,
1996). The inclusion of alteration of the perceived defect is important in alerting health care workers to
assess for body dysmorphic disorder in individuals presenting to cosmetic surgeons or dermatologists
(Mufaddel et al., 2013). The vast majority of individuals with body dysmorphic disorder engage in some
form of camouflaging of their perceived defects (Phillips et al., 1995), which can make it difficult to
assess for the degree to which the defect is unnoticeable or slightly noticeable to others. Awareness of
this fact guides the clinician to take steps to obtain objective information about the body part or region
from collateral sources. Similar to anxiety and fear-related disorders and other OCRD, avoidance
behaviours are commonly seen in body dysmorphic disorder and are included as a possible variant of
repetitive behaviours partly because of their association with significant impairments in social and
occupational functioning.
Several lines of evidence support the inclusion of body dysmorphic disorder among the OCRD (Veale
and Matsunaga, 2014). First, at a phenomenological level, body dysmorphic disorder and OCD share
features of intrusive thoughts or images and repetitive behaviours. Specifically, individuals affected by
body dysmorphic disorder experience persistent, unwanted thoughts about their perceived defects or
flaws in appearance (Osman et al., 2004) and perform a variety of repetitive behaviours associated
with these preoccupations. Second, there are high rates of co-occurrence of body dysmorphic disorder
and OCD (Bienvenu et al., 2012). Furthermore, like OCD, body dysmorphic disorder symptoms,
including presentations where insight is absent, respond to serotonin reuptake inhibitors (Phillips et
al., 2002) and cognitive-behavioural therapy (Veale et al., 2014) rather than to treatments that target
psychotic symptoms. Finally, including a separate diagnostic option of body dysmorphic disorder is
intended to address underdiagnosis and undertreatment of the disorder (Zimmerman and Mattia,
1998) by prompting health care workers to assess for its presence, thus improving the clinical utility of
the classification.
The proposed ICD-11 diagnostic guidelines for body dysmorphic disorder differentiate it from both
normal preoccupations with appearance and from other disorders that share similar features. The
description of the perceived defects or flaws in body dysmorphic disorder as being either unnoticeable
or only slightly noticeable to others is intended to differentiate it from self-consciousness about actual
physical problems. Self-consciousness in social anxiety disorder is differentiated from a similar
phenomenon in body dysmorphic disorder because it takes the form of fear of negative evaluation
about the individual’s behaviour or physiological manifestations of anxiety (e.g., sweating, flushing,
and tremor) rather than a perceived bodily deformity.
A major source of confusion in the appropriate diagnosis of body dysmorphic disorder has been the
extent to which manifestly untrue beliefs about one’s appearance and the reaction of others to it
should be regarded as psychotic symptoms. Reflecting this confusion, the ICD-10 diagnostic guidelines
for delusional disorder specifically mention “a conviction that the individual’s body is misshapen” as an

example of a delusion that may characterize the disorder. The proposed ICD-11 diagnostic guidelines
indicate that some individuals with body dysmorphic disorder can acknowledge that their thoughts or
behaviours are untrue or excessive, but others cannot, and the beliefs of some individuals with body
dysmorphic disorder may at times appear delusional in intensity or fixity (e.g., an individual is
convinced that he is hideously ugly). Moreover, beliefs related to the reactions of others to their flaws
or defects may resemble ideas or delusions of self-reference (e.g., the conviction that people are taking
notice, judging, or talking about the perceived defects or flaws) (Hrabosky et al., 2009, Mancuso et al.,
2010). According to the proposed ICD-11 diagnostic guidelines, if such beliefs are restricted to the fear
or conviction of having a flawed appearance or bodily defect in an individual without a history of other
delusions and in the absence of other features of psychosis (e.g., hallucinations or formal thought
disorder), and are fully consistent with the other clinical features of the disorder, then body
dysmorphic disorder and not delusional disorder is the appropriate diagnosis. This change in
conceptualization from ICD-10 is consistent with the way that distorted beliefs about body shape or
weight have been conceptualized in the diagnosis of anorexia nervosa and the way in which strongly
held beliefs about the nature of obsessions and compulsions are viewed in the context of OCD.

4. Olfactory reference disorder
The Working Group has recommended the addition of olfactory reference disorder to ICD-11, the
essential features of which include persistent preoccupation with a perceived foul or offensive body
odour or breath (Pryse-Phillips, 1971) that is either unnoticeable or slightly noticeable to others such
that the individual’s concerns are markedly disproportionate to the smell (see Table 1). Perceived
odours reported in the literature include those originating from the mouth, genitals, anus, feet,
underarms, urine, sweat, and occasionally non-bodily odours. Affected individuals fear or are
convinced that others noticing the smell will reject or humiliate them, and this is associated with
various affective responses including anxiety, shame, and depressed mood (Veale and Matsunaga,
2014). In Japan, olfactory reference disorder symptoms are considered a form of taijin kyofoshu
referred to as jiko-shu-kyofu (Suzuki et al., 2004).
Similar to body dysmorphic disorder, for a diagnosis of olfactory reference disorder, intrusive
preoccupations must be accompanied by associated repetitive behaviours intended to eradicate the
perceived odour or ensure that others do not smell it (Phillips and Menard, 2011) or by avoidance
behaviours. Common behaviours include checking for body odour, checking the perceived source of
the smell, camouflaging the perceived odour, and seeking reassurance (Malasi et al., 1990, PrysePhillips, 1971). Furthermore, avoidance of social situations, present in up to 75% of individuals with
olfactory reference disorder (Phillips and Menard, 2011), or avoidance of triggers that increase distress
about the perceived odour is common. In a clinical sample, olfactory reference disorder symptoms
resulted in about half of participants avoiding occupational, academic, or other important role
activities, or being completely housebound for at least a week (Phillips and Menard, 2011).

There are several reasons for including olfactory reference disorder among the OCRD. The disorder
shares phenomenological similarity with other OCRD with respect to the presence of persistent
intrusive preoccupations and associated repetitive behaviours. Furthermore, OCD is commonly
comorbid with olfactory reference disorder (Prazeres et al., 2010) and its inclusion among OCRD
highlights the importance of considering the disorder during the differential diagnostic process.
Although olfactory reference disorder appears to have low prevalence, patients may be ashamed of
their symptoms and instead report more acceptable symptoms such as those associated with a
depressive disorder, OCD, or social anxiety disorder (Phillips et al., 2005), which are, in fact, often cooccurring with or consequences of olfactory reference disorder (Malasi et al., 1990). Furthermore,
because the concerns are related to body functioning, many affected individuals present to primary
care or to medical specialties other than psychiatry and the separate diagnostic label is expected to
raise awareness of the condition. Although olfactory reference disorder is an under-researched
phenomenon, case reports in the literature suggest, that similar to other OCRD, there may be a
preferential response to serotonin reuptake inhibitors (Begum and McKenna, 2011, Prazeres et al.,
2010, Teraishi et al., 2012).
The proposed ICD-11 diagnostic guidelines help to distinguish olfactory reference disorder from other
disorders that share similar features. In particular, self-consciousness in social anxiety disorder is
distinguished from that observed in olfactory reference disorder in the same way as for body
dysmorphic disorder. As in body dysmorphic disorder, patients presenting with olfactory reference
disorder in the absence of an appropriate diagnostic category may be unhelpfully diagnosed as having
a delusional disorder or other psychotic disorder. In one clinical sample, 85% of patients with olfactory
reference disorder were characterized as delusional about their conviction that they emit a foul or
offensive odour (Prazeres et al., 2010), although much lower prevalence has been reported for another
sample (Phillips and Menard, 2011). The proposed diagnostic guidelines remind clinicians that
preoccupations in olfactory reference disorder can appear similar to ideas or delusions of selfreference, but should be considered to be wholly consistent with the condition.

5. Hypochondriasis
The Working Group has recommended retaining the core diagnostic features of hypochondriasis, called
hypochondriacal disorder in ICD-10, but moving it from the grouping of Somatoform Disorders In ICD10 to the newly proposed OCRD grouping in ICD-11. Hypochondriasis is a well-characterized disorder in
which affected individuals have persistent preoccupations with the possibility of having one or more
serious diseases (see Table 1) (Stein, 2012). These concerns may involve life-threatening diseases (e.g.
cancer, AIDS), severe progressive diseases (e.g. multiple sclerosis), or in rare cases even severe mental
disorders (e.g., schizophrenia). Preoccupations are associated with catastrophic misinterpretation of
one or more bodily signs or symptoms, including normal or commonplace sensations. The person
attributes these bodily signs or symptoms to the suspected disease and engages in a variety of

behaviours intended to establish diagnosis or prognosis. In some cases, this may be manifested in
avoidance of health care rather than seeking of medical information or attention.
The proposed ICD-11 diagnostic guidelines specify that in addition to preoccupations about having a
serious illness, a positive diagnosis must include repetitive and excessive behaviours or maladaptive
avoidance related to health, though the nature and extent of these behaviours may change over the
course of the disorder. Repetitive and avoidance behaviours are important targets of treatment
(Warwick and Salkovskis, 2001). Among repetitive behaviours commonly observed in affected
individuals are checking their bodies and bodily functions for signs of illness, spending excessive
amounts of time searching for information about a presumed illness, and repeatedly seeking
reassurance from health professionals about their health status (Rachman, 2012, Warwick and
Salkovskis, 1990). Common avoidance behaviours include attempts at suppressing disease-related
cognitions, not scheduling medical appointments, and evasion of triggering situations or objects.
The Working Group considered a range of evidence related to the potential placement of
hypochondriasis in the OCRD grouping, in a grouping with other disorders that were included in the
ICD-10 grouping of Somatoform Disorders, or in the Anxiety and Fear-Related Disorders grouping. The
recommendation not to include hypochondriasis in a grouping of Somatoform Disorders is based on
the fact that the presence of somatic symptoms is not an essential feature of hypochondriasis (van den
Heuvel et al., 2014), although they may occur transiently and be a focus of considerable preoccupation
when they do. Moreover, unlike in individuals with Somatoform Disorder, reassurance and appropriate
medical examination is typically reassuring to patients with hypochondriasis, at least in the short term
(Creed and Gureje, 2012). Hypochondriasis has been found to have high rates of co-occurrence and
familiality with other OCRD (Bienvenu et al., 2012). Somatoform Disorders, notably somatization
disorder, also frequently co-occurs with hypochondriasis (Barsky et al., 1992, Noyes et al., 1994, Rief et
al., 1998), however, this may reflect overreliance in earlier classifications on shared rather than distinct
features to define these disorders. Finally, hypochondriasis unlike Somatoform Disorders,
demonstrates similar response to treatments used for OCRD including serotonin reuptake inhibitors
and cognitive-behavioural treatments including adapted exposure and response prevention (Greeven
et al., 2009, Greeven et al., 2007).
The weight of the evidence supporting the placement of hypochondriasis in the OCRD grouping as
opposed to the Anxiety and Fear-Related Disorders grouping is less clear. Hypochondriasis shares
important clinical features with both OCD and with Anxiety and Fear-Related Disorders, in particular
panic disorder (Neziroglu et al., 2000). Individuals with OCD often report illness related concerns, such
as fears of contamination, as do those with panic disorder in their catastrophic misinterpretation of
bodily sensations as evidence of illness (Clark, 1986). Unlike hypochondriasis, illness concerns in panic
disorder are typically only present during panic attacks with inter-episode preoccupations focused
primarily on the reoccurrence of panic. Furthermore, panic attacks can occur in the context of many
forms of psychopathology including the OCRD and Anxiety and Fear-Related Disorders. Nevertheless,
anxiety remains the most common affective response to hypochondriacal preoccupations.

Neurobiological studies of hypochondriasis, OCD, and panic disorder provide evidence of overlapping
neuropsychological and neurocircuitry features among these disorders (Creed and Gureje, 2012, van
den Heuvel et al., 2011, van den Heuvel et al., 2005). The Working Group’s recommendation to include
hypochondriasis among the OCRD was ultimately based on the phenomenological similarities in terms
of the presence of intrusive preoccupations and repetitive behaviours such as repeated checking of the
body for signs of illness, searching for information about a perceived illness, and seeking reassurance
from health professionals (Rachman, 2012). However, in recognition of the overlap with anxiety and
fear-related disorders, the Working Group has also recommended that hypochondriasis be crossreferenced in the ICD-11 grouping of Anxiety and Fear-Related Disorders (van den Heuvel et al., 2014).
The Working Group has also recommended that the alternate title of health anxiety disorder be
included for hypochondriasis (see Table 1) because of its prevalent use in the clinical literature (Tyrer
and Tyrer, 2014).

6. Hoarding disorder
The Working Group has recommended that hoarding disorder be added to the OCRD grouping.
Hoarding disorder is characterized by an excessive attachment to a large number of possessions,
regardless of their actual value, resulting in excessive acquisition and failure to discard items, such that
living spaces become cluttered and their use compromised (see Table 1 for core diagnostic features).
Hoarding behaviours may be exhibited as a part of a broad range of Mental and Behavioural Disorders
and other conditions (Mataix-Cols et al., 2013), including OCD, Depressive Disorders, schizophrenia,
dementia syndrome, autism spectrum disorder, and Prader–Willi syndrome (Fontenelle and Grant,
2014). However, the Working Group determined that there is now sufficient evidence that hoarding
behaviour accompanied by other essential features should be regarded as a separate and unique
mental disorder. For example, a large epidemiological study concluded that the disorder is distinct
from OCD and other disorders and that the disorder has a population estimate of 5.8% (Timpano et al.,
2011). Individuals affected by hoarding disorder are under-recognized and undertreated, which argues
from a public health perspective for its inclusion in the classification (Mataix-Cols et al., 2010).
According to the proposed ICD-11 diagnostic guidelines, the essential features of hoarding disorder
include: (1) excessive accumulation of and attachment to possessions, regardless of their actual value;
(2) repetitive urges or behaviours related to buying, stealing or amassing items; and (3) difficulty
discarding items due to a perceived need to save items and distress associated with discarding them
(see Table 1). Although the existence of a variant of the disorder that does not involve excessive
acquisition has also been suggested (Timpano et al., 2011), the evidence suggests that those who deny
current acquisition problems often report active avoidance of cues that might trigger a desire to
acquire items and that they tend to exhibit excessive acquisition when such cues are no longer avoided
(Frost et al., 2013). The proposed ICD-11 diagnostic guidelines also indicate that significant distress or
functional impairment is also a required feature of the disorder, to distinguish hoarding from
collecting, and it is most commonly the excessive acquisition of items that is associated with distress

and impairment and produces threats to health and safety. Excessive attachment to hoarded items,
regardless of their actual value, may occur for a variety of reasons (Steketee and Frost, 2003), and is
distinct from cognitive phenomena common in other OCRD, such as obsessions in OCD (Mataix-Cols et
al., 2013). Inclusion of the requirement for difficulty discarding items, alongside excessive acquisition,
is consistent with recent evidence that both belong to a one-dimensional hoarding phenotype (Meyer
et al., 2013).
The diagnostic requirement that excessive acquisition and failure to discard items in hoarding disorder
result in cluttered living spaces whose use or safety are compromised is intended to differentiate
clinically significant hoarding from normal accumulation of items and collecting. One assumption that
is made in this definition is that clinically significant hoarding cannot occur in the absence of clutter.
However, the extent to which clutter may be present and/or interfere with usual activities may vary
(e.g., depending on resources and available space), and various possibilities were considered for
setting a reasonable threshold for the diagnosis. A field trial of the DSM-5 criterion that requires “key”
living spaces to be sufficiently cluttered so as to preclude activities for which those spaces were
designed (APA, 2013), which is similar to earlier definitions of hoarding (Frost and Hartl, 1996), was
considered too strict because it resulted in not assigning the diagnosis to individuals who were
significantly distressed and impaired and met all other diagnostic criteria for hoarding disorder, yet still
managed to somehow use some of their “key” living spaces (Mataix-Cols et al., 2013). The proposed
ICD-11 guidelines use a somewhat more flexible threshold of “use or safety being compromised.”
The presence of positive affective responses to acquisition behaviours observed in individuals with
hoarding disorder raises the question of whether the disorder might be more appropriately considered
an Impulse Control Disorder (Steketee and Frost, 2003). The Working Group considered this
formulation but opted against it because inability to discard items cannot be considered an impulsive
behaviour and also because some compulsions in OCD, such as symmetry-related behaviours, may also
be experienced as pleasurable. The strongest support for including hoarding disorder in the OCRD
grouping comes from phenomenological similarities with OCD, whereby individuals with hoarding
disorder engage in repetitive behaviours in the form of excessive acquisition alongside avoidance of
discarding objects in order to diminish or avoid distress (Fontenelle and Grant, 2014, Mataix-Cols et al.,
2010). Moreover, there are also important differences in symptomatology, and treatments for OCD
such as serotonin reuptake inhibitors and exposure and response prevention appear to be less
effective among individuals with hoarding disorder (Mathews, 2014), who tend to require adjunctive
strategies such as motivational interviewing and adaptations to CBT protocols (Steketee et al., 2010).
Therefore, hoarding disorder may not fit as neatly or unequivocally into the OCRD grouping as the
other disorders described above. However, the Working Group considered that, on balance, its
inclusion in this grouping is the most clinically useful placement option given currently available
evidence.

7. Insight qualifier in OCRD
Varying proportions of individuals with OCD, body dysmorphic disorder, olfactory reference disorder,
hypochondriasis, and hoarding disorder at times appear to lack insight about the irrationality of their
thoughts and behaviours to such an extent that their convictions of the veracity of associated beliefs
(e.g., that failing to enact a ritual will results in catastrophic consequences, that one is hideously
deformed, that one has a life-threatening illness, and that possessions cannot be discarded) may at
times appear to be delusional in intensity or fixity. In the past, this has caused some presentations of
these disorders to be misdiagnosed as delusional or other psychotic disorders, for example as
discussed above for body dysmorphic disorder. According to the proposed diagnostic guidelines, if
beliefs are restricted to ideation that is specifically related to psychopathology of the OCRD, occur
entirely in the context of symptomatic episodes of the disorder, and in the absence of other features of
psychosis, they should be regarded as fully consistent with the OCRD diagnosis and the individual
should not be diagnosed with delusional disorder. Support for this diagnostic approach is also derived
from studies demonstrating that effective treatments for OCRD, irrespective of the level of insight,
differ from those for psychotic disorders (O’Dwyer and Marks, 2000, Veale and Matsunaga, 2014,
Wilhelm et al., 2014).
At the same time, the intensity or fixity of the individual’s beliefs exhibited as part of an OCRD is likely
to be relevant for selection of a treatment approach—for example, different cognitive treatments
involve different degrees of direct confrontation with the individual’s beliefs—and as predictors of
treatment adherence and prognosis (Himle et al., 2006, Phillips et al., 2014). The Working Group has
therefore recommended the inclusion of a qualifier for level of insight that can be applied across the
OCRD categories described above. For the purpose of this qualifier, insight refers to the extent to
which a person is convinced that her or his obsessions, preoccupations, repetitive behaviours, or
beliefs about the relationship between these phenomena reflect objective truths, and is meant to
include overvalued ideas (Veale, 2002). Level of insight is expected to vary with the evolution of the
disorder, the current level of stress and symptoms, and in response to somatic and psychosocial
treatments.
The insight qualifier captures the spectrum of conviction with which disorder-specific beliefs are held
with what the Working Group considered sufficient granularity to be clinically useful. Each disorder can
be assigned one of three distinct levels as follows: (1) with fair to good insight, which characterizes
individuals who think that their beliefs are probably untrue or are regularly able to entertain the
possibility that their beliefs may not be true; (2) with poor insight, which characterizes individuals who
think that their beliefs are probably true; and (3) no insight, which characterizes individuals for who, all
or almost all of the time, are completely convinced that the beliefs are true.
Although the insight qualifier is intended to be applicable to OCD, body dysmorphic disorder, olfactory
reference disorder, hypochondriasis, and hoarding disorder, the base rates for levels of insight
associated with each diagnostic category likely vary. For example, data suggest that lack of insight is

relatively uncommon in OCD (Eisen and Rasmussen, 1993), significantly higher in body dysmorphic
disorder with approximately half of patients affected (Phillips et al., 1997, Veale et al., 1996), and may
range up to 85% in olfactory reference disorder depending on the sample (Phillips and Menard, 2011,
Prazeres et al., 2010). Future research using the proposed level of insight qualifier will help to clarify its
utility and its association with factors such as prognosis and genetic factors.

8. Body-Focused Repetitive Behaviour Disorders
The Working Group has proposed including a new subgrouping of Body-Focused Repetitive Behaviour
Disorders within the OCRD, encompassing trichotillomania (hair-pulling disorder) and excoriation (skinpicking) disorder, which are characterized by recurrent and habitual actions directed at the integument
(see Table 1). Inclusion of a subgrouping of Body-Focused Repetitive Behaviour Disorders grouping
reflects evidence that these disorders share more in common with each other than with other OCRD
(Lochner et al., 2002). Trichotillomania was previously classified as a “habit and impulse disorder” in
ICD-10 whereas excoriation disorder is a new proposed diagnostic entity. Hair-pulling and skin-picking
are included as named categories in the subgrouping because they are the most prevalent of these
conditions, and the most likely to be accompanied by distress and impairment (Keuthen et al., 2010,
Odlaug and Grant, 2008), but other bodily targets of repetitive behaviour such as nail biting and nose
picking, can be classified under the residual category of other body-focused repetitive behaviour
disorders if they meet the other essential diagnostic requirements.
The essential features of trichotillomania and excoriation disorder are repetitive and persistent pulling
of hair or picking of skin resulting in hair loss or skin lesions, respectively. In addition, individuals with
these disorders must have demonstrated attempts to stop or decrease these compulsive behaviours.
There is no requirement that patients experience relief or gratification from hair or skin removal, a
feature that was omitted based on findings that there are no important clinical differences in
individuals who did and did not report this experience (Lochner et al., 2012a, Lochner et al., 2012b).
Instead, the proposed ICD-11 diagnostic guidelines indicate that Body-Focused Repetitive Behaviour
Disorders may be associated with a variety of reported effects including regulation of affect and
arousal, tension reduction, and pleasure, all of which are presumed to reinforce repetitive behaviours.
Patients are also found to have varying degrees of awareness of their hair pulling or skin picking
behaviour. Importantly, the guidelines emphasize that in the aftermath of hair pulling or skin picking,
many individuals report a variety of negative affects, such as a sense of loss of control or shame.
Finally, rather than providing clinicians with arbitrary, non-evidenced based counting rules for
elements such as the duration of symptoms and time spent performing behaviours to differentiate
normality from pathology, these are referred to more flexibly to allow for appropriate clinical
judgment.
Body-Focused Repetitive Behaviour Disorders are distinct from other OCRD in that they are rarely
preceded by cognitive phenomena such as intrusive thoughts, obsessions, or preoccupations, but
instead may be preceded by sensory experiences (Grant and Stein, 2014). However, their inclusion in

the OCRD grouping is based on evidence of their relatedness to OCD in terms of shared
phenomenology, patterns of familial aggregation, and aetiologic mechanisms (Grant et al., 2012). At
the phenomenological level, the behaviours in Body-Focused Repetitive Behaviour Disorders are often
accompanied by urges, and once performed relieve anxiety (or hyperarousal). At the neurobiological
level there is evidence of fronto-striatal circuitry dysfunction as is observed in other OCRD
(Chamberlain et al., 2008). Finally, Body-Focused Repetitive Behaviour Disorders frequently co-occur
with OCD (Lochner et al., 2005).
In comparison to other OCRD, Body-Focused Repetitive Behaviour Disorders call for distinct
assessment methods that may include physical examination and reports from collateral informants.
Treatment approaches also differ somewhat, and include the use of habit reversal, dopamine
antagonists, and modulators of glutamate. It has been suggested that Body-Focused Repetitive
Behaviour Disorders might better be considered an Impulse Control Disorder because some patients
report relief and gratification from the behaviour similar to those who engage in other impulsive
activities (e.g., kleptomania), impulsive traits appear to co-occur frequently with Body-Focused
Repetitive Behaviour Disorders, and there may be high familiality with Disorders due to Substance Use
(Hollander et al., 2009). The Working Group decided that the evidence was stronger for the
classification of these disorders among the OCRD.
The proposed guidance distinguishing Body-Focused Repetitive Behaviour Disorder from other
disorders indicates that in other OCRD, particularly OCD and body dysmorphic disorder, hair pulling
and skin picking behaviours may be present but performed in response to disorder-specific
obsessions/preoccupations, for example to achieve symmetry in OCD or to alter appearance in body
dysmorphic disorder. Stereotyped movement disorder is distinct from Body-Focused Repetitive
Behaviour Disorders because of the presence of seemingly driven and nonfunctional motor behaviours
such as head banging, body rocking, self-biting, generally composed of patterned and predictable
coordinated movements, that emerge at a very early age (Freeman et al., 2010). Finally, clinicians are
alerted to other health conditions (e.g., skin inflammation) as well as patterns of substance use (e.g.,
dopamine releasing drugs) that may be associated with repetitive behaviours targeting the
integument.

9. Cross-referenced disorders: Tourette syndrome and personality disorder
with anankastic features
The ICD-11 classification includes a system of “multiple parenting,” which allows diagnostic categories
found in other chapters or groupings to be cross-referenced when these could legitimately be placed in
more than one section of the classification. Multiple parenting is intended to enhance clinical utility by
ensuring that health care providers will consider cross-referenced disorders in differential diagnosis or
in recognizing co-morbidities that affect treatment planning and implementation. ICD-11 entities
proposed for cross-referencing in the ORD grouping include Tourette syndrome, which is primary

parented in the ICD-11 chapter on Diseases of the Nervous System, and personality disorder with
anankastic features from the Personality Disorders grouping.
The Working Group has recommended that Tourette syndrome be cross-referenced to the OCRD
grouping for several reasons (Woods and Thomsen, 2014). First, studies of Tourette syndrome have
demonstrated its high comorbidity with OCD (Freeman et al., 2000;Scharf et al., 2012). Second, factor
analytic studies suggest that complex tics are highly related to OCD severity (Alsobrook and Pauls,
2002), and symmetry-related obsessions are associated with tic symptoms (McKay et al., 2004). Third,
there is evidence for a familial link between OCD and Tourette syndrome (Davis et al., 2013). Brain
imaging studies also suggest that these disorders both involve disruption in cortico-striatothalamocortical pathways (Milad and Rauch, 2012). Finally, OCD and Tourette syndrome share the
phenomenology of repetitive behaviours serving to temporarily reduce aversive experiences, primarily
obsessions in the case of OCD, and sensory “premonitory urges” in the case of Tourette syndrome
(Miguel et al., 1995). The essential features proposed for a diagnosis of Tourette syndrome in ICD-11
(Woods and Thomsen, 2014) include the presence of one or more motor tics and one or more vocal
tics, which may or may not manifest concurrently or continuously, over a period of at least one year
with onset during the developmental period. The guidelines emphasize that tics wax and wane through
time (e.g., worsening during periods of stress) (Woods and Thomsen, 2014). The proposed guidelines
recognize the challenge of differentiating Tourette syndrome from OCD, and specify that repetitive,
recurrent movements or vocalizations in Tourette syndrome are differentiated because they appear
unintentional in nature, clearly utilize a discrete muscle group, and are not aimed at neutralizing
obsessions or reducing anxiety. The guidelines also recognize that the disorders can co-occur, and
indicate that both diagnoses may be assigned if the full essential features of both disorders are
present.
The ICD-11 Working Group on Personality Disorders has proposed a major revision to this section of
the classification reflecting accruing evidence regarding the dimensionality of personality pathology
(Bernstein et al., 2007) and the lack of the validity of existing personality disorder categories (Skodol et
al., 2005). As proposed for ICD-11, assignment of a personality disorder diagnosis is based on the
presence of a general pervasive and persistent disturbance in inter- and intrapersonal functioning,
which is then rated according to the severity of the disturbance (Tyrer et al., 2015). The personality
disorder can also be qualified according to trait domains that describe the underlying personality
structure. These include an “anankastic features” domain that describes individuals who exhibit
perfectionism, extreme need to control their own and others’ behaviour, and rigid adherence to rules.
This variant of personality disorders is proposed for cross-referencing to the OCRD grouping because of
the significant similarities in phenomenology (although there are also important differences such as a
lack of distressing obsessions and time consuming compulsions) as well as co-occurrence with
disorders that manifest in compulsive behaviour (Coles et al., 2008, Phillips and McElroy, 2000, Pinto et
al., 2006). Personality disorder with anankastic features is highly co-occurring with OCD and also shares
a significant familial link (Bienvenu et al., 2012, Samuels et al., 2000). Furthermore, there is recent
evidence for a neuropsychological profile reflecting cognitive inflexibility and perseveration in non-

clinical cases of personality disorder with anankastic features that matches that of individuals with OCD
(Fineberg et al., 2015).

10. Conclusion and limitations
The ICD-11 Working Group surveyed the evidence and placed a high priority on clinical utility in
proposing a new grouping of Obsessive–Compulsive and Related Disorders. The proposal is informed
by studies indicating that the disorders included in the grouping have similarities with respect to a
number of validators including neurocircuitry (Milad and Rauch, 2012), neurochemistry (e.g., Nikolaus
et al., 2010), familiality (Bienvenu et al., 2012), and genetic risk factors (Monzani et al., 2014).
Furthermore, they frequently co-occur (Lochner et al., 2005) and have overlapping responses to
specific psychopharmacological and psychotherapeutic treatments (Fineberg et al., 2014).
The Working Group proposed revisions to the guidelines for the OCRD intended to enhance clinical
utility, paying particular attention to the fact that the ICD will be used to diagnose conditions globally
in primary care and specialty settings with varied resources. It is anticipated that the creation of the
OCRD grouping and the inclusion of several new conditions (i.e., body dysmorphic disorder, hoarding
disorder, olfactory reference disorder, and excoriation disorder) will contribute to accurate
identification of patients so that they receive services in a more timely manner as well as to research
efforts aimed at improving our understanding of the prevalence, assessment, and treatment of these
disorders.
Alternative nosological conceptualizations have been described in the literature and vary substantially.
These range from proposing that the disorders slated for inclusion in the ICD-11 OCRD grouping be
placed in existing groupings such as anxiety disorders, somatoform disorders, and impulse control
disorders to proposing a broader OCRD concept along an impulsive–compulsive continuum that would
also incorporate a variety of other groupings of disorders (e.g., Impulse Control Disorders, attention
deficit hyperactivity disorder, and in some formulations Substance Abuse Disorders and Feeding and
Eating Disorders). Although alternative taxonomies have some merit and empirical basis, the proposed
ICD-11 OCRD grouping and diagnostic guidelines were developed to achieve the goals of maximizing
clinical utility and global applicability. Further work is needed to determine whether these goals were
attained.
The proposals described in this article will be systematically tested in field studies administered via the
internet using standardized case material (Evans et al., 2015) as well as with real patients in clinical
settings (Keeley et al., in press), based on which they will be modified prior to finalization for
submission to the World Health Assembly. Mental health and primary care professionals interested in
participating in field studies for ICD-11 Mental and Behavioural Disorders are encouraged to register in
any of nine languages as a part of the Global Clinical Practice Network (Reed et al., 2015) at
www.globalclinicalpractice.net.
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